Target intelligence / Profile preview

Osmotic gradients in airway mucus and extracellular fluid

Molecular classification
Physiological process, Biophysical mechanism
01

Overview

Osmotic gradients in the airway mucus and extracellular fluid represent a critical physiological target for the treatment of muco-obstructive lung diseases. These gradients are primarily regulated by the active transport of ions across the airway epithelium, which dictates the movement of water into or out of the airway surface liquid (ASL) (Boucher, R. C., 2007, Journal of Internal Medicine). In a healthy respiratory system, the balance of ion transport—primarily through the cystic fibrosis transmembrane conductance regulator (CFTR) and the epithelial sodium channel (ENaC)—maintains an osmotic environment that ensures mucus remains hydrated and easily cleared by ciliary action. In diseases such as cystic fibrosis, the loss of chloride secretion and excessive sodium absorption lead to a dehydrated ASL and hyper-concentrated mucus, which impairs mucociliary clearance and facilitates chronic infection (Elkins, M. R., et al., 2006, NEJM). Therapeutic intervention involves the administration of inhaled osmotic agents like hypertonic saline or mannitol. These agents increase the osmotic pressure within the airway lumen, drawing water from the submucosal space to rehydrate the mucus, thereby improving its rheological properties and facilitating mechanical clearance via coughing or ciliary movement (Daviskas, E., et al., 2010, Chest).

Other names
Airway surface liquid hydrationASL osmotic pressureMucus osmolarityTracheal osmotic gradientAirway surface liquid (ASL) volume regulation
02

Mechanism of action

Osmotic agents increase the solute concentration in the airway surface liquid (ASL), creating an osmotic pressure gradient that draws water from the epithelial cells and interstitial space into the mucus layer to improve hydration and rheology (Boucher, 2007; Elkins et al., 2006).

03

Biological functions

Mucociliary clearanceAirway hydrationOsmoregulationFluid homeostasisInnate immune defense
04

Disease associations

Cystic FibrosisBronchiectasisChronic Obstructive Pulmonary Disease (COPD)
05

Safety considerations

BronchospasmCoughChest tightnessThroat irritationHemoptysis (in severe bronchiectasis)
06

Interacting drugs

Hypertonic saline

2 more in the full profile.

07

Biomarkers

Forced Expiratory Volume in 1 second (FEV1)Mucociliary clearance (MCC) rateSputum rheology (viscosity and elasticity)Airway surface liquid (ASL) height (in vitro)

Beyond the preview

Go deeper on Osmotic gradients in airway mucus and extracellular fluid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Osmotic gradients in airway mucus and extracellular fluid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call